Imidazopyridin-2-one derivatives
US9315518B2 · kind B2 · utility
0Cited by
12References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2012 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Jun 14, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to imidazopyridin-2-one derivatives which are potentiators of metabotropic glutamate receptors, particularly the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.